arrow
M

Michael A. Morse

Duke University
H指数:81
被引数:2.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CD27 agonism enhances long-lived CD4 T cell vaccine responses critical for antitumor immunity
2025-12-190
PRE
MDS PD e-Diary: A New Patient-Centered Digital Tool in Development for People with Parkinson's Disease

MDS PD e-Diary:为帕金森病患者开发的一种新型以患者为中心的数字工具

2025-12-010
OA
Percutaneous transcatheter valve replacement in individuals with mitral regurgitation unsuitable for surgery or transcatheter edge-to-edge repair: a prospective, multicountry, single-arm trial

经皮经导管瓣膜置换术在二尖瓣反流、不适合手术或经导管边缘对边缘修复的受试者中的应用:一项前瞻性、多国、单臂试验

2025-10-270
PRE
Inflammation and mutational burden differentially associated with nivolumab or ipilimumab combination efficacy in colorectal cancer

炎症和突变负担与nivolumab或ipilimumab联合疗法的疗效在结直肠癌中存在差异关联。

2025-10-060
OAAI
Mid-Term Outcomes of Balloon-Expandable Aortic Valve-in-Valve Replacement in the United States

美国球囊扩张型主动脉瓣中位随访期瓣中瓣置换术的中期结果

2025-08-250
OAAI
Advances in the treatment of hepatocellular carcinoma: An overview of the current and evolving therapeutic landscape for clinicians

肝细胞癌治疗进展:临床医生当前和不断演变的治疗格局概述

2025-05-200
OAAI
Clinical impact of concurrent autologous adoptive T cells immunotherapy in active COVID-19 infected cancer patients for chemotherapy

自体过继T细胞免疫疗法对活动性COVID-19感染的化疗癌症患者的临床影响

2025-04-090
OA
Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)

有效的细胞外载荷释放和免疫调节相互作用决定了曲妥珠单抗德鲁替康(T-DXd)的疗效。

2025-04-021
OA
Evaluating Mitral TEER in the Management of Moderate Secondary Mitral Regurgitation Among Heart Failure Patients

评估二尖瓣经导管边缘到边缘修复术在心力衰竭患者中度继发性二尖瓣反流管理中的应用

2025-02-015
OAAI
ASO Visual Abstract: Adjuvant Cytotoxic Chemotherapy May Not Be Associated with a Survival Advantage for Resected Intrahepatic Cholangiocarcinoma
2025-01-280
PRE
Adjuvant Cytotoxic Chemotherapy may not be Associated with a Survival Advantage for Resected Intrahepatic Cholangiocarcinoma
2025-01-181
PRE
1-Year Outcomes From the CLASP IID Randomized Trial for Degenerative Mitral Regurgitation

退行性二尖瓣反流的CLASP IID随机试验的1年结果

2023-12-014
OAAI
1-Year Outcomes With Fourth-Generation Mitral Valve Transcatheter Edge-to-Edge Repair From the EXPAND G4 Study

来自扩展G4研究的第四代二尖瓣经导管边缘到边缘修复的1年结果

2023-11-0126
OAAI
Expanding the Spectrum of TEER Suitability Evidence From the EXPAND G4 Post Approval Study
2023-06-0118
OAAI